Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Correction: Palmitate Conditions Macrophages for Enhanced Responses toward Inflammatory Stimuli via JNK Activation.

Riera-Borrull M, Cuevas VD, Alonso B, Vega MA, Joven J, Izquierdo E, Corbí ÁL.

J Immunol. 2019 Jun 7. pii: ji1900602. doi: 10.4049/jimmunol.1900602. [Epub ahead of print] No abstract available.


Macrophage-specific MHCII expression is regulated by a remote Ciita enhancer controlled by NFAT5.

Buxadé M, Huerga Encabo H, Riera-Borrull M, Quintana-Gallardo L, López-Cotarelo P, Tellechea M, Martínez-Martínez S, Redondo JM, Martín-Caballero J, Flores JM, Bosch E, Rodríguez-Fernández JL, Aramburu J, López-Rodríguez C.

J Exp Med. 2018 Nov 5;215(11):2901-2918. doi: 10.1084/jem.20180314. Epub 2018 Oct 16.


Metformin Potentiates the Benefits of Dietary Restraint: A Metabolomic Study.

Riera-Borrull M, García-Heredia A, Fernández-Arroyo S, Hernández-Aguilera A, Cabré N, Cuyàs E, Luciano-Mateo F, Camps J, Menendez JA, Joven J.

Int J Mol Sci. 2017 Oct 28;18(11). pii: E2263. doi: 10.3390/ijms18112263.


Palmitate Conditions Macrophages for Enhanced Responses toward Inflammatory Stimuli via JNK Activation.

Riera-Borrull M, Cuevas VD, Alonso B, Vega MA, Joven J, Izquierdo E, Corbí ÁL.

J Immunol. 2017 Dec 1;199(11):3858-3869. doi: 10.4049/jimmunol.1700845. Epub 2017 Oct 23. Erratum in: J Immunol. 2019 Jun 7;:.


Metformin administration induces hepatotoxic effects in paraoxonase-1-deficient mice.

García-Heredia A, Riera-Borrull M, Fort-Gallifa I, Luciano-Mateo F, Cabré N, Hernández-Aguilera A, Joven J, Camps J.

Chem Biol Interact. 2016 Apr 5;249:56-63. doi: 10.1016/j.cbi.2016.03.004. Epub 2016 Mar 3.


Exploring the effects of the atherosclerosis progression and the choice of affected arteries in the design of experiments with Apolipoprotein E-deficient mice.

Riera-Borrull M, Sabench F, del Castillo D, Camps J, Joven J.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):82-6. doi: 10.1016/j.arteri.2015.10.005. Epub 2016 Feb 15.


Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.

Riera-Borrull M, Rodríguez-Gallego E, Hernández-Aguilera A, Luciano F, Ras R, Cuyàs E, Camps J, Segura-Carretero A, Menendez JA, Joven J, Fernández-Arroyo S.

J Am Soc Mass Spectrom. 2016 Jan;27(1):168-77. doi: 10.1007/s13361-015-1262-3. Epub 2015 Sep 17.


Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways.

Izquierdo E, Cuevas VD, Fernández-Arroyo S, Riera-Borrull M, Orta-Zavalza E, Joven J, Rial E, Corbi AL, Escribese MM.

J Immunol. 2015 Sep 1;195(5):2442-51. doi: 10.4049/jimmunol.1403045. Epub 2015 Jul 24.


Understanding the role of circulating chemokine (C-C motif) ligand 2 in patients with chronic ischemia threatening the lower extremities.

Rull A, Hernandez-Aguilera A, Fibla M, Sepulveda J, Rodríguez-Gallego E, Riera-Borrull M, Sirvent JJ, Martín-Paredero V, Menendez JA, Camps J, Joven J.

Vasc Med. 2014 Dec;19(6):442-51. doi: 10.1177/1358863X14554034. Epub 2014 Oct 21.


Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases.

Camps J, Rodríguez-Gallego E, García-Heredia A, Triguero I, Riera-Borrull M, Hernández-Aguilera A, Luciano-Mateo F, Fernández-Arroyo S, Joven J.

Adv Clin Chem. 2014;63:247-308. Review.


Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease.

Rodríguez-Gallego E, Guirro M, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R, Fernández-Arroyo S, Beltrán-Debón R, Sabench F, Hernández M, del Castillo D, Menendez JA, Camps J, Ras R, Arola L, Joven J.

Int J Obes (Lond). 2015 Feb;39(2):279-87. doi: 10.1038/ijo.2014.53. Epub 2014 Mar 28.


Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.

Rodríguez-Gallego E, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R, Rull A, Beltrán-Debón R, Luciano-Mateo F, Menendez JA, Vazquez-Martin A, Sirvent JJ, Martín-Paredero V, Corbí AL, Sierra-Filardi E, Aragonès G, García-Heredia A, Camps J, Alonso-Villaverde C, Joven J.

Mediators Inflamm. 2013;2013:953841. doi: 10.1155/2013/953841. Epub 2013 Dec 15.


A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.

Fernández-Sender L, Alonso-Villaverde C, Rull A, Rodríguez-Gallego E, Riera-Borrull M, Hernández-Aguilera A, Camps J, Beltrán-Debón R, Aragonès G, Menendez JA, Joven J.

AIDS Res Ther. 2013 May 9;10(1):11. doi: 10.1186/1742-6405-10-11.


Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.

Hernández-Aguilera A, Rull A, Rodríguez-Gallego E, Riera-Borrull M, Luciano-Mateo F, Camps J, Menéndez JA, Joven J.

Mediators Inflamm. 2013;2013:135698. doi: 10.1155/2013/135698. Epub 2013 Feb 28. Review.


Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Menendez JA, Joven J, Aragonès G, Barrajón-Catalán E, Beltrán-Debón R, Borrás-Linares I, Camps J, Corominas-Faja B, Cufí S, Fernández-Arroyo S, Garcia-Heredia A, Hernández-Aguilera A, Herranz-López M, Jiménez-Sánchez C, López-Bonet E, Lozano-Sánchez J, Luciano-Mateo F, Martin-Castillo B, Martin-Paredero V, Pérez-Sánchez A, Oliveras-Ferraros C, Riera-Borrull M, Rodríguez-Gallego E, Quirantes-Piné R, Rull A, Tomás-Menor L, Vazquez-Martin A, Alonso-Villaverde C, Micol V, Segura-Carretero A.

Cell Cycle. 2013 Feb 15;12(4):555-78. doi: 10.4161/cc.23756. Epub 2013 Jan 31.


Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.

Joven J, Menéndez JA, Fernandez-Sender L, Espinel E, Rull A, Beltrán-Debón R, Rodríguez-Gallego E, Riera-Borrull M, Pedro-Botet J, Alonso-Villaverde C, Camps J, Aragonès G.

HIV Med. 2013 Apr;14(4):233-40. doi: 10.1111/hiv.12000. Epub 2012 Nov 21.


Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism.

Joven J, Rull A, Rodriguez-Gallego E, Camps J, Riera-Borrull M, Hernández-Aguilera A, Martin-Paredero V, Segura-Carretero A, Micol V, Alonso-Villaverde C, Menéndez JA.

Food Chem Toxicol. 2013 Jan;51:267-79. doi: 10.1016/j.fct.2012.10.004. Epub 2012 Oct 11. Review.


Supplemental Content

Loading ...
Support Center